Renalytix (Reg S) (RENX)

Sector:

Health Care

Index:

FTSE AIM All-Share

8.85p
   
  • Change Today:
    -1.15p
  • 52 Week High: 12.50
  • 52 Week Low: 5.62
  • Currency: UK Pounds
  • Shares Issued: 189.93m
  • Volume: 14,407,578
  • Market Cap: £16.81m
  • RiskGrade: 348
  • Beta: 0.08

RENX Overview

RenalytixAI is a developer of artificial intelligence (AI) enabled clinical decision support solutions for kidney disease, one of the most common and costly chronic medical conditions globally. RenalytixAI’s solutions are being designed to make significant improvements in kidney disease risk assessment, clinical care and patient stratification for drug clinical trials.

1 Day Chart (23-09-2025)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1293.5% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 9.9 n/a
Pr/Book n/a  
Latest F'cast
Revenue -32.7% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

RENX Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-20 n/a (10.61) (16.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-21 1.49 (35.79) (43.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-22 2.97 (49.63) (78.00)¢ n/a n/a n/a n/a 0.0%
30-Jun-23 3.40 (45.60) (55.00)p n/a n/a n/a n/a 0.0%
30-Jun-24 2.29 (33.45) (31.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

RENX Company Announcements

Investor Presentation and Revised Revenue Guidance 23-Sep-2025 07:00 RNS
Result of Fundraise 22-Sep-2025 17:30 RNS
WRAP Retail Offer for up to £500,000 22-Sep-2025 07:01 RNS

RENX ShareCast News

Renalytix shares more than double after striking... 15-Sep-2025 ShareCast
Renalytix enters new collaboration with NYKHM 03-Jun-2025 ShareCast
Renalytix Q3 revenues up 20pc 10-Apr-2025 ShareCast

Latest RENX Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

RENX Market Data

Currency UK Pounds
Share Price 8.85p
Change Today -1.15p
% Change -11.50 %
52 Week High 12.50
52 Week Low 5.62
Volume 14,407,578
Shares Issued 189.93m
Market Cap £16.81m
Beta 0.08
RiskGrade 348

RENX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
19.57% above the market average19.57% above the market average19.57% above the market average19.57% above the market average19.57% above the market average
51.52% above the sector average51.52% above the sector average51.52% above the sector average51.52% above the sector average51.52% above the sector average
Price Trend
92.18% below the market average92.18% below the market average92.18% below the market average92.18% below the market average92.18% below the market average
77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average77.14% below the sector average
Income Not Available
Growth
28.37% below the market average28.37% below the market average28.37% below the market average28.37% below the market average28.37% below the market average
37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average37.14% below the sector average

RENX Dividends

No dividends found

Trades for 23-Sep-2025

Time Volume / Share Price
17:03 400,000 @ 9.00p
16:29 11,067 @ 8.95p
16:24 251,871 @ 9.33p
16:29 1,752 @ 8.79p
16:28 59,732 @ 8.85p

RENX Key Personnel

CEO James Renwick McCullough

Top of Page